• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间质性膀胱炎症状指数与问题指数。

The interstitial cystitis symptom index and problem index.

作者信息

O'Leary M P, Sant G R, Fowler F J, Whitmore K E, Spolarich-Kroll J

机构信息

Department of Surgery, Harvard Medical School, Boston, MA, USA.

出版信息

Urology. 1997 May;49(5A Suppl):58-63. doi: 10.1016/s0090-4295(99)80333-1.

DOI:10.1016/s0090-4295(99)80333-1
PMID:9146003
Abstract

OBJECTIVES

To develop 2 brief self-administered indices for measuring lower urinary tract symptoms and their impact in patients with interstitial cystitis (IC).

METHODS

An initial set of questions was developed and evaluated in focus groups. The index was revised, shortened, and validated with patients diagnosed in 3 large urologic practices with experience in interstitial cystitis (N = 45). Controls were recruited from a group of healthy volunteers in a gynecology clinic (N = 67). Internal consistency, construct validity, and test-retest reliability were evaluated.

RESULTS

The IC symptom index and the IC problem index measure urinary and pain symptoms and assesses how problematic symptoms are for patients with interstitial cystitis. Psychometric performance of both instruments is good, with the symptom index demonstrating excellent ability to discriminate characteristics between patients and controls.

CONCLUSION

Both indices should be useful in the evaluation and management of patients with IC and should be particularly useful in clinical trials of new therapies for this condition, where reliable, validated, and reproducible outcome measures are critically important.

摘要

目的

制定2个简短的自我管理指标,用于测量间质性膀胱炎(IC)患者的下尿路症状及其影响。

方法

初步设计了一组问题并在焦点小组中进行评估。该指标经过修订、缩短,并在3家有间质性膀胱炎诊疗经验的大型泌尿外科诊所确诊的患者中进行了验证(N = 45)。对照组从一家妇科诊所的一组健康志愿者中招募(N = 67)。评估了内部一致性、结构效度和重测信度。

结果

IC症状指标和IC问题指标可测量泌尿和疼痛症状,并评估这些症状对间质性膀胱炎患者的问题程度。两种工具的心理测量性能良好,症状指标显示出区分患者和对照组特征的卓越能力。

结论

这两个指标在IC患者的评估和管理中都应有用,并且在针对这种疾病的新疗法的临床试验中应特别有用,在这些试验中,可靠、经过验证且可重复的结果测量至关重要。

相似文献

1
The interstitial cystitis symptom index and problem index.间质性膀胱炎症状指数与问题指数。
Urology. 1997 May;49(5A Suppl):58-63. doi: 10.1016/s0090-4295(99)80333-1.
2
Reliability and validity of Turkish versions of the interstitial cystitis symptom index and interstitial cystitis problem index.土耳其语版间质性膀胱炎症状指数和间质性膀胱炎问题指数的信度和效度。
Neurourol Urodyn. 2020 Nov;39(8):2338-2343. doi: 10.1002/nau.24492. Epub 2020 Aug 26.
3
[Efficiency of O'Leary-Sant symptom index and problem index in the diagnosis of interstitial cystitis].[O'Leary-Sant症状指数和问题指数在间质性膀胱炎诊断中的效能]
Zhonghua Yi Xue Za Zhi. 2013 Nov 12;93(42):3347-50.
4
Efficiency of questionnaires used to screen for interstitial cystitis.用于筛查间质性膀胱炎的问卷的有效性。
J Urol. 2006 Aug;176(2):587-92. doi: 10.1016/j.juro.2006.03.035.
5
Psychometric validation of the O'leary-Sant interstitial cystitis symptom index in a clinical trial of pentosan polysulfate sodium.在聚磺苯乙烯钠临床试验中对奥利里-桑特间质性膀胱炎症状指数进行心理测量学验证。
Urology. 2001 Jun;57(6 Suppl 1):62-6. doi: 10.1016/s0090-4295(01)01126-8.
6
The bladder pain/interstitial cystitis symptom score: development, validation, and identification of a cut score.膀胱疼痛/间质性膀胱炎症状评分:制定、验证和确定临界值。
Eur Urol. 2012 Feb;61(2):271-9. doi: 10.1016/j.eururo.2011.10.004. Epub 2011 Oct 18.
7
Assessment of treatment outcomes of interstitial cystitis with hydrodistention and bladder training by O'Leary-Sant Interstitial Cystitis Symptom and Problem Indices.采用奥利里-桑特间质性膀胱炎症状与问题指数评估膀胱水扩张联合膀胱训练治疗间质性膀胱炎的疗效。
Taiwan J Obstet Gynecol. 2018 Oct;57(5):718-721. doi: 10.1016/j.tjog.2018.08.019.
8
Statistical validation of the shorter-moldwin food sensitivity questionnaire for patients with interstitial cystitis/bladder pain syndrome.针对间质性膀胱炎/膀胱疼痛综合征患者的较短版莫德温食物敏感性问卷的统计学验证
J Urol. 2014 Jun;191(6):1793-801. doi: 10.1016/j.juro.2013.11.055. Epub 2013 Dec 5.
9
Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity.间质性膀胱炎患病率增加:使用新的症状问卷和膀胱内钾敏感性识别出先前未被认识的泌尿外科和妇科病例。
Urology. 2002 Oct;60(4):573-8. doi: 10.1016/s0090-4295(02)01829-0.
10
Correlation between 2 interstitial cystitis symptom instruments.两种间质性膀胱炎症状评估工具之间的相关性
J Urol. 2005 Mar;173(3):835-40. doi: 10.1097/01.ju.0000152672.83393.61.

引用本文的文献

1
Hormonal Contraception Use and Risk of Lower Urinary Tract Symptoms and Conditions: Findings From the Boston Area Community Health Survey.激素避孕的使用与下尿路症状及疾病风险:来自波士顿地区社区健康调查的结果
Int Urogynecol J. 2025 Aug 14. doi: 10.1007/s00192-025-06271-2.
2
Variability in the Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome: Internet Survey.间质性膀胱炎/膀胱疼痛综合征诊断与治疗的差异:网络调查
JMIR Form Res. 2025 Aug 5;9:e70813. doi: 10.2196/70813.
3
Patient Related Outcomes for Interstitial Cystitis/Bladder Pain Syndrome Recommendations for Clinical Trials and General Urology Practice.
间质性膀胱炎/膀胱疼痛综合征的患者相关结局:临床试验和普通泌尿外科实践的建议
Neurourol Urodyn. 2025 Sep;44(7):1455-1465. doi: 10.1002/nau.70107. Epub 2025 Jul 7.
4
Bladder capacity as a benchmark for patient stratification in interstitial cystitis/bladder pain syndrome.膀胱容量作为间质性膀胱炎/膀胱疼痛综合征患者分层的基准。
Continence (Amst). 2023 Dec;8. doi: 10.1016/j.cont.2023.101051. Epub 2023 Oct 24.
5
Resilience among adults with chronic urologic pelvic pain syndrome: A flexible self-regulation perspective.成年慢性盆底疼痛综合征患者的心理弹性:灵活自我调节视角
J Pain. 2025 Jul;32:105439. doi: 10.1016/j.jpain.2025.105439. Epub 2025 May 15.
6
Hypoparathyroidism is associated with bladder dysfunction, a preliminary study.甲状旁腺功能减退与膀胱功能障碍相关:一项初步研究
Sci Rep. 2025 Apr 29;15(1):14949. doi: 10.1038/s41598-025-98867-3.
7
Clinical epidemiology of young men with lower urinary tract symptoms: The SciCOM 3 project.患有下尿路症状的年轻男性的临床流行病学:SciCOM 3项目。
Indian J Urol. 2025 Apr-Jun;41(2):137-144. doi: 10.4103/iju.iju_429_24. Epub 2025 Apr 1.
8
Oral esketamine for patients with severe treatment-resistant depression: Effectiveness, safety, and tolerability of a six-week open-label treatment program.口服艾司氯胺酮治疗重度难治性抑郁症患者:一项为期六周的开放标签治疗方案的有效性、安全性和耐受性
J Psychopharmacol. 2025 Jun;39(6):559-570. doi: 10.1177/02698811251332831. Epub 2025 Apr 25.
9
Lipidomic analysis coupled with machine learning identifies unique urinary lipid signatures in patients with interstitial cystitis/bladder pain syndrome.脂质组学分析结合机器学习可识别间质性膀胱炎/膀胱疼痛综合征患者独特的尿液脂质特征。
World J Urol. 2025 Apr 18;43(1):233. doi: 10.1007/s00345-025-05628-y.
10
2025 Canadian Urological Association Guideline: Selected treatment recommendations for interstitial cystitis/bladder pain syndrome.《2025年加拿大泌尿外科协会指南:间质性膀胱炎/膀胱疼痛综合征的选定治疗建议》
Can Urol Assoc J. 2025 Apr;19(4):90-103. doi: 10.5489/cuaj.9182.